Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China
· Delayed Price · Currency is CNY 16.21
+0.96 (6.30%)
Apr 29, 2026, 3:04 PM CST
SHE:002755 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 14,154 | 15,157 | 11,797 | 10,043 | 7,370 | 11,815 | Upgrade
|
| Market Cap Growth | -15.65% | 28.48% | 17.47% | 36.27% | -37.63% | -2.53% | Upgrade
|
| Enterprise Value | 11,799 | 12,801 | 9,955 | 8,433 | 5,757 | 10,477 | Upgrade
|
| Last Close Price | 15.25 | 16.33 | 12.63 | 10.75 | 7.89 | 12.52 | Upgrade
|
| PE Ratio | 57.07 | 64.06 | 73.60 | - | - | 31.10 | Upgrade
|
| Forward PE | - | 15.30 | 15.30 | 15.30 | 15.30 | 15.30 | Upgrade
|
| PS Ratio | 7.96 | 8.52 | 6.64 | 6.96 | 3.94 | 3.80 | Upgrade
|
| PB Ratio | 4.32 | 4.63 | 3.75 | 3.34 | 2.45 | 3.66 | Upgrade
|
| P/TBV Ratio | 5.37 | 5.75 | 4.05 | 3.59 | 2.57 | 3.79 | Upgrade
|
| P/FCF Ratio | 27.86 | 29.83 | 65.20 | - | - | 27.23 | Upgrade
|
| P/OCF Ratio | 21.72 | 23.26 | 28.68 | - | - | 20.81 | Upgrade
|
| EV/Sales Ratio | 6.46 | 7.20 | 5.60 | 5.84 | 3.08 | 3.37 | Upgrade
|
| EV/EBITDA Ratio | 42.57 | 35.25 | 58.61 | - | - | 26.11 | Upgrade
|
| EV/EBIT Ratio | 57.96 | 54.07 | 105.29 | - | - | 33.83 | Upgrade
|
| EV/FCF Ratio | 23.22 | 25.20 | 55.02 | - | - | 24.14 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.01 | 0.02 | 0.04 | 0.02 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.09 | 0.42 | - | - | 0.03 | Upgrade
|
| Debt / FCF Ratio | 0.02 | 0.07 | 0.40 | - | - | 0.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.73 | -0.75 | -0.64 | -0.54 | -0.52 | -0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.66 | -6.74 | -11.90 | 7.84 | 6.94 | -4.17 | Upgrade
|
| Net Debt / FCF Ratio | -6.95 | -4.82 | -11.17 | 10.50 | 7.65 | -3.86 | Upgrade
|
| Asset Turnover | 0.40 | 0.42 | 0.47 | 0.42 | 0.53 | 0.83 | Upgrade
|
| Inventory Turnover | 2.22 | 2.19 | 1.83 | 1.80 | 1.73 | 1.78 | Upgrade
|
| Quick Ratio | 2.52 | 2.37 | 2.85 | 4.62 | 6.05 | 5.69 | Upgrade
|
| Current Ratio | 2.73 | 2.56 | 3.13 | 5.07 | 6.60 | 6.19 | Upgrade
|
| Return on Equity (ROE) | 8.07% | 6.66% | 4.18% | -6.89% | -8.53% | 12.16% | Upgrade
|
| Return on Assets (ROA) | 4.25% | 3.45% | 1.56% | -5.23% | -5.48% | 5.14% | Upgrade
|
| Return on Invested Capital (ROIC) | 29.20% | 20.53% | 6.43% | -20.51% | -20.79% | 18.50% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.60% | 7.10% | 2.90% | -9.40% | -10.10% | 9.30% | Upgrade
|
| Earnings Yield | 1.67% | 1.56% | 1.36% | -1.48% | -3.06% | 3.21% | Upgrade
|
| FCF Yield | 3.59% | 3.35% | 1.53% | -1.55% | -2.76% | 3.67% | Upgrade
|
| Dividend Yield | 0.79% | - | 0.95% | - | - | 0.80% | Upgrade
|
| Payout Ratio | 47.11% | 47.11% | 0.72% | - | - | 48.89% | Upgrade
|
| Buyback Yield / Dilution | -0.37% | -0.37% | -1.57% | 1.34% | -1.55% | -0.16% | Upgrade
|
| Total Shareholder Return | 0.42% | -0.37% | -0.62% | 1.34% | -1.55% | 0.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.